PaxMedica, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PaxMedica, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2021 to Q1 2024.
  • PaxMedica, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$3.69M, a 3.67% increase year-over-year.
  • PaxMedica, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$18.1M, a 11.5% increase year-over-year.
  • PaxMedica, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18.3M, a 23.6% decline from 2022.
  • PaxMedica, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.8M, a 44.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$18.1M -$3.69M +$141K +3.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$18.3M -$5.92M -$700K -13.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$17.6M -$5.05M +$6.41M +56% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-16
Q2 2023 -$24M -$3.49M -$3.51M -18418% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$20.5M -$3.83M -$5.7M -306% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$14.8M -$5.22M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$11.5M -$8.35M -269% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-16
Q2 2022 $19K +$6.15M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.86M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 -$3.11M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$6.13M Apr 1, 2021 Jun 30, 2021 10-Q 2022-09-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.